Form 8-K - Current report:
SEC Accession No. 0001213900-25-051593
Filing Date
2025-06-05
Accepted
2025-06-05 16:30:43
Documents
12
Period of Report
2025-06-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0244830-8k_ispecimen.htm   iXBRL 8-K 36610
  Complete submission text file 0001213900-25-051593.txt   204047

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ispc-20250604.xsd EX-101.SCH 3017
3 XBRL LABEL FILE ispc-20250604_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ispc-20250604_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0244830-8k_ispecimen_htm.xml XML 3782
Mailing Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101
Business Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 251027541
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)